| dc.contributor | 神科所 | |
| dc.creator (作者) | 陳玠文 | |
| dc.creator (作者) | Chen, Hong-Jhe;Ou, Hsun;Shen, Jia-Ying;Chung, Chi-Hsiang;Hung, Yuan;Chen, Chieh-Wen;Stubbs, Brendon;Chien, Wu-Chien;Chen, Tien-Yu | |
| dc.date (日期) | 2026-04 | |
| dc.date.accessioned | 7-May-2026 10:32:44 (UTC+8) | - |
| dc.date.available | 7-May-2026 10:32:44 (UTC+8) | - |
| dc.date.issued (上傳時間) | 7-May-2026 10:32:44 (UTC+8) | - |
| dc.identifier.uri (URI) | https://ah.lib.nccu.edu.tw/item?item_id=182358 | - |
| dc.description.abstract (摘要) | Zolpidem is a common sleep medication, but its cardiac safety was previously unclear. This study used Taiwan’s national database to analyze over 450 000 individuals and found that zolpidem use is associated with a nearly 2-fold increase in the risk of arrhythmia, particularly fast heartbeats like atrial flutter and paroxysmal tachycardia. These findings suggest that patients and doctors should carefully weigh the cardiac risks before starting treatment, and those with existing heart conditions may benefit from regular heart monitoring while using this medication to ensure overall safety. | |
| dc.format.extent | 109 bytes | - |
| dc.format.mimetype | text/html | - |
| dc.relation (關聯) | Journal of the Chinese Medical Association, Vol.89, No.4, pp.284-292 | |
| dc.subject (關鍵詞) | Arrhythmia; Benzodiazepines; Cardiovascular disease; Zolpidem | |
| dc.title (題名) | Zolpidem use and the risk of arrhythmia: a nationwide population-based cohort study in Taiwan | |
| dc.type (資料類型) | article | |
| dc.identifier.doi (DOI) | 10.1097/JCMA.0000000000001360 | |
| dc.doi.uri (DOI) | https://doi.org/10.1097/jcma.0000000000001360 | |
